Related Experiment Video
Updated: Apr 17, 2026
04:34
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.8K
[Insomnia: cognitive behavioral therapy better than pills]
Nynke L Rauwerda1,2, Mette H Bakker3
1Ziekenhuis Gelderse Vallei, afd. Medische Psychologie, Ede.
Nederlands Tijdschrift Voor Geneeskunde
|April 16, 2026
Summary
Cognitive Behavioral Therapy for Insomnia (CBT-I) offers effective, long-lasting relief for chronic insomnia, outperforming medication with fewer side effects. This approach empowers patients toward better sleep and overall well-being.
Area of Science:
- Sleep Medicine
- Behavioral Science
Background:
- Chronic insomnia is prevalent, causing significant patient burden and increasing comorbidity risk.
- Current pharmacological treatments have limitations, including short-term efficacy and potential side effects.
Purpose of the Study:
- To illustrate the practical implementation of Cognitive Behavioral Therapy for Insomnia (CBT-I) through a representative case study.
- To highlight CBT-I's effectiveness as a first-line treatment for chronic insomnia, including medication tapering.
Main Methods:
- The case study details the application of core CBT-I components, including behavioral techniques (e.g., sleep restriction) and cognitive interventions.
- The approach focused on addressing insomnia's maintaining factors and restoring daytime balance.
Main Results:
- CBT-I demonstrates strong, long-lasting effects with fewer side effects compared to pharmacotherapy.
- Clinically relevant improvements are observed in up to 80% of patients, even those with comorbid conditions.
Conclusions:
- CBT-I is a highly effective and sustainable treatment for chronic insomnia, promoting patient autonomy.
- Barriers to wider CBT-I implementation include limited awareness, access, and reimbursement.
More Related Videos
Related Concept Videos
01:19Management of Insomnia
803
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
803
01:27Insomnia
611
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
611
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
939
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
939
01:14CNS Depressants: Barbiturates and Benzodiazepines
1.8K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.8K
01:23Sedatives and Hypnotics: Overview
2.2K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
2.2K
01:17Sleepwalking and Sleep Talking
1.6K
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
1.6K